1. Ali MJ, Davison PD, Pickett W, Ali NS: ACC/AHA guidelines as predictors of postoperative cardiac outcomes. Canadian Journal of Anaesthesia 47 (2000) 10-19 WR Hiatt, M Hunink, J Isner, J Lammer, L Norgren, J Novo, B Ricco, ... surgery 135, 847-857, 2001 | | 2001 |
17 CHAPTER Pathophysiology of Peripheral Artery Disease, Intermittent Claudication, and Critical Limb Ischemia WR Hiatt, EP Brass Vascular Medicine E-Book: A Companion to Braunwald's Heart Disease, 223, 2012 | | 2012 |
2143 Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial YT Wu, HK Yu, LR Chen, CN Chang, YM Chen, GC Hu, AF Moraska, ... | | |
2259 Ticagrelor in patients wtih symptomatic peripheral artery disease and prior coronary artery disease J Berger, G Heizer, I Baumgartner, FGR Fowkes, P Held, BG Katona, ... European Heart Journal 38 (suppl_1), ehx502. 2259, 2017 | | 2017 |
238 A randomized, double-blind placebo-controlled study of NV1FGF gene therapy in critical limb ischemia patients (TAMARIS Study): Rationale, design and baseline patient … E Van Belle, S Nikol, L Norgren, I Baumgartner, V Driver, W Hiatt, J Bech Archives of Cardiovascular Diseases Supplements 3 (1), 77-78, 2011 | 1 | 2011 |
4065 Moderate to severe renal insufficiency and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: the EUCLID trial CW Hopley, S Kavanagh, M Patel, I Baumgartner, JS Berger, JI Blomster, ... European Heart Journal 39 (suppl_1), ehy563. 4065, 2018 | | 2018 |
6-minute Walk Test Variability May be Reduced by a Structured Training and Monitoring Program, Potentially Facilitating Detection of Treatment Effects JA Hsia, MP Bonaca, R White, V Anderson, WR Hiatt Circulation 142 (Suppl_3), A13462-A13462, 2020 | | 2020 |
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association AT Hirsch, MA Allison, AS Gomes, MA Corriere, S Duval, AG Ershow, ... Circulation 125 (11), 1449-1472, 2012 | 357 | 2012 |
A comparison of cilostazol and pentoxifylline for treating intermittent claudication DL Dawson, BS Cutker, WR Hiatt ACC Current Journal Review 3 (10), 29-30, 2001 | 3 | 2001 |
A comparison of cilostazol and pentoxifylline for treating intermittent claudication DL Dawson, BS Cutler, WR Hiatt, RW Hobson, JD Martin, EB Bortey, ... | | 1999 |
A comparison of cilostazol and pentoxifylline for treating intermittent claudication DL Dawson, BS Cutler, WR Hiatt, RW Hobson II, JD Martin, EB Bortey, ... The American journal of medicine 109 (7), 523-530, 2000 | 613 | 2000 |
A comparison of cilostazol and pentoxifylline for treating intermittent laudication DL Dawson, BS Cutler, WR Hiatt ACP JOURNAL CLUB 134 (3), 105-105, 2001 | | 2001 |
A Contemporary Assessment of Lipid Lowering Therapies and Low-density Lipoprotein Cholesterol in Peripheral Artery Disease CN Hess, CP Cannon, JA Beckman, P Goodney, MR Patel, E Shannon, ... Circulation 142 (Suppl_3), A14141-A14141, 2020 | | 2020 |
A critical review of antiplatelet treatment in peripheral arterial disease F Violi, W Hiatt Internal and Emergency Medicine 2, 84-87, 2007 | 7 | 2007 |
A high ankle brachial index is associated with increased cardiovascular disease morbidity and worse quality of life MA Allison, MH Criqui, WR Hiatt, AT Hirsch JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 49 (9), 405A-405A, 2007 | 1 | 2007 |
A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life MA Allison, WR Hiatt, AT Hirsch, JR Coll, MH Criqui Journal of the American College of Cardiology 51 (13), 1292-1298, 2008 | 233 | 2008 |
A model-based approach to analyzing ankle-brachial index: Results from the action for health in diabetes study group MA Espeland, JG Regensteiner, WR Hiatt, LE Wagenknecht, J Bahnson, ... CIRCULATION 113 (8), E357-E357, 2006 | | 2006 |
A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER TRIAL OF THE SAFETY AND EFFICACY OF PLASMID DNA EXPRESSING 2 ISOFORMS OF HEPATOCYTE GROWTH FACTOR IN … EC Perin, F Mendelsohn, M Davies, H Pham, J Saucedo, A Hirsch, ... Journal of the American College of Cardiology 63 (12S), A2092-A2092, 2014 | 2 | 2014 |
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication EP Brass, LT Cooper, RE Morgan, WR Hiatt Journal of vascular surgery 55 (2), 381-389. e1, 2012 | 27 | 2012 |
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication RL Pande, WR Hiatt, P Zhang, N Hittel, MA Creager Vascular medicine 15 (3), 181-188, 2010 | 134 | 2010 |